注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Beyond Air Inc是一家商业化医疗器械和生物制药公司,开发了一个能够从环境空气中生成NO的一氧化氮(NO)发生器和输送系统平台(LungFit平台)。该公司的LungFit平台可用于治疗无需呼吸机的患者,以及通过呼吸面罩或类似器械进行递送的慢性或急性严重肺部感染患者。该公司的重点领域是新生儿持续性肺动脉高压(PPHN)、社区获得性病毒性肺炎(CAVP),包括新冠肺炎、毛细支气管炎(BRO)、非结核分枝杆菌(NTM)肺部感染以及各种严重肺部感染伴潜在的慢性阻塞性肺疾病(COPD)。LungFit PH是一种电离器技术,可从环境空气中按需生成一氧化氮,并将其输送至呼吸机回路,而不考虑剂量或流量。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
William P. Forbes | 60 | 2018 | Independent Director |
Yossef Av-Gay | 60 | 2011 | Member of Scientific Advisory Board |
Richard Malley | - | - | Member of Scientific Advisory Board |
Steven Adam Lisi | 51 | 2017 | CEO & Chairman of the Board |
Ron Bentsur | 56 | 2017 | Independent Director |
Hannah Blau | - | - | Member of Scientific Advisory Board |
David Greenberg | 62 | - | Member of Scientific Advisory Board |
Erick Lucera | 54 | 2017 | Independent Director |
Stacey Martiniano | - | - | Member of Scientific Advisory Board |
Yoori Lee | 49 | 2018 | Independent Director |
Robert F. Carey | 63 | 2019 | Independent Director |
Amir Avniel | 50 | 2011 | Co-Founder, President, Chief Business Officer & Director |
Andrew R. Colin | - | 2013 | Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核